Medical Marijuana Policy Research: Exploring Trends and Impacts (R01)
Total Grant Amounts: Approximately $10 million over the five year period.
This FOA, issued by the National Institute on Drug Abuse (NIDA), solicits Research Project Grant (R01) applications from institutions/organizations that propose research on medical marijuana-related “quasi-natural experiments” in the US to understand the effects of changing local laws, regulations, and policies on the epidemiology of cannabis or other drug and alcohol use including the use of tobacco. These quasi- natural experiments may utilize a community or other population-level law, regulation, or public policy intervention that affects medical marijuana use (i.e. decriminalization, etc.). To address this objective, applicants should propose research studies that will assess social, behavioral, and public health impacts of medical marijuana use and policies. The results of research supported by this FOA are expected to provide critical epidemiologic and evaluation data to inform local, regional, and national public policy and public health research relevant to marijuana use across the Nation.
Research topics that fall within the scope of this FOA include but are not limited to the following:
Epidemiologic research on the prevalence, incidence, patterns, and emerging trends in the varying medical marijuana policy environment across states or localities, or before and after law, regulation, or policy change.
Studies of the effects of medical marijuana laws, regulations, and policies on key health and social indicators, such as rates of use of other drugs, tobacco, and alcohol, rates of corollary risk and protective health behaviors; sexually transmitted infections and HIV; substance abuse treatment admission; truancy, academic performance, school dropout; arrests for drug buying or selling, criminality, accidents associated with drugged driving; and employment outcomes.
Research to explore the impact of medical marijuana laws, regulations, and policies in the context of HIV/AIDS, including the use of medical marijuana among people living with HIV and its effects on health, decision making, adherence to HAART and retention in HIV care, and risky sexual behaviors.
Research to understand the effects of medical marijuana laws, regulations, and policies on social norms, attitudes, beliefs, perceptions of harm and disapproval, and drug use behaviors of youth, adults, and parents in communities where the laws have changed, or who live with family members who use medical marijuana, or who have friends who use nonmedical marijuana and other drugs. Studies exploring how changes in norms influence epidemiologic trends are also of interest.
National Institute on Drug Abuse
City Agencies Colleges/Universities Commercial Organizations Community Based Organizations County Agencies Educational Organizations/Institutions Federal Government Agencies International Agencies IRS 501 (c)(3) Organizations Nonprofit Organizations Religious Organizations Schools State Agencies Tribal Organizations
Number of Awards Given
4 to 5 awards
Award Amount Notes
Applications may request budgets with direct costs up to $500,000 per year and time periods up to five years in duration, for a total of approximately $10 million over the five year period.
Behavioral Research Drug Abuse Epidemiological Research Health Care Policies Medical Treatments and Therapies Research Programs
Local Government Agencies Policy Makers Researchers State Government Agencies
Applicants must download the SF424 (R&R) application package associated with this funding opportunity using the “Apply for Grant Electronically” button in this FOA or following the directions provided at Grants.gov.
It is critical that applicants follow the instructions in the SF424 (R&R) Application Guide (http://grants.nih.gov/grants/funding/424/SF424_RR_Guide_General_Adobe_VerB.pdf), except where instructed in this funding opportunity announcement to do otherwise. Conformance to the requirements in the Application Guide is required and strictly enforced. Applications that are out of compliance with these instructions may be delayed or not accepted for review.
Disclaimer: NPIN provides this information as a public service only. The views and information provided about the materials, funding opportunities, and organizations do not necessarily state or reflect those of the U.S. Department of Health and Human Services, CDC, or NPIN.